These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 5271990)

  • 1. Clinical tolerance to cycloserine.
    Schmelev NA
    Scand J Respir Dis Suppl; 1970; 71():226-30. PubMed ID: 5271990
    [No Abstract]   [Full Text] [Related]  

  • 2. Tolerance to cycloserine.
    Riska N
    Scand J Respir Dis Suppl; 1970; 71():209-16. PubMed ID: 5271988
    [No Abstract]   [Full Text] [Related]  

  • 3. [Changes in the bioelectric activity of the brain in patients with pulmonary tuberculosis during intolerance cycloserine].
    Shmelev NA; Shabalova LN
    Antibiotiki; 1970 Dec; 15(12):1120-5. PubMed ID: 5501372
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical tolerance to cycloserine.
    Stephanopoulos C; Zoumbouloglou H
    Scand J Respir Dis Suppl; 1970; 71():235-8. PubMed ID: 5271993
    [No Abstract]   [Full Text] [Related]  

  • 5. Cycloserine and clinical phthisiology.
    Zapatero J; Garcia Moreno F; Torres G; Santamaria A; Ventura A
    Scand J Respir Dis Suppl; 1970; 71():252-5. PubMed ID: 5271996
    [No Abstract]   [Full Text] [Related]  

  • 6. Neurologic and behavioural reactions of tuberculous patients treated with cycloserine.
    Pasargiklian M; Biondi L
    Scand J Respir Dis Suppl; 1970; 71():201-8. PubMed ID: 5271987
    [No Abstract]   [Full Text] [Related]  

  • 7. Considerations and remarks on the tolerance of cycloserine.
    Grassi C
    Scand J Respir Dis Suppl; 1970; 71():250-1. PubMed ID: 5271995
    [No Abstract]   [Full Text] [Related]  

  • 8. On cycloserine in the treatment of pulmonary tuberculosis and its use for postoperative protection.
    Rivas Salazar JL
    Scand J Respir Dis Suppl; 1970; 71():314-24. PubMed ID: 5272002
    [No Abstract]   [Full Text] [Related]  

  • 9. Results of treatment of pulmonary tuberculosis with cycloserine in association with other drugs.
    Bethlem N
    Scand J Respir Dis Suppl; 1970; 71():244-9. PubMed ID: 5271994
    [No Abstract]   [Full Text] [Related]  

  • 10. Experience with cycloserine.
    Dissmann E
    Scand J Respir Dis Suppl; 1970; 71():239-43. PubMed ID: 5317744
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical experience with cycloserine in the treatment of tuberculosis.
    Mitchell RS; Lester W
    Scand J Respir Dis Suppl; 1970; 71():94-108. PubMed ID: 4917144
    [No Abstract]   [Full Text] [Related]  

  • 12. [Psychoses caused by cycloserine].
    Gori EC; Teti V
    G Ital Mal Torace; 1968; 22(6):359-68. PubMed ID: 5729888
    [No Abstract]   [Full Text] [Related]  

  • 13. [Changes in the electroencephalogram and neuro-psychic disorders in patients with pulmonary tuberculosis during treatment with cycloserine].
    Chelnokova NV
    Antibiotiki; 1968 Oct; 13(10):918-25. PubMed ID: 5707364
    [No Abstract]   [Full Text] [Related]  

  • 14. Neurotoxic effects of cycloserine therapy in pulmonary tuberculosis of adolescents and young adults.
    Bucco T; Meligrana G; De Luca V
    Scand J Respir Dis Suppl; 1970; 71():259-65. PubMed ID: 5271998
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effect of isonicotinic acid hydrazide and cycloserine on the central nervous system].
    Korzeniewska-Koseła M
    Pneumonol Pol; 1983; 51(8-9):483-7. PubMed ID: 6359077
    [No Abstract]   [Full Text] [Related]  

  • 16. Psychosomatic reactions to cycloserine in the treatment of tuberculosis.
    Leston JM; Rey JC; Gonzalez Montaner LJ; Grondona A; Zavalla PN
    Scand J Respir Dis Suppl; 1970; 71():231-4. PubMed ID: 5271992
    [No Abstract]   [Full Text] [Related]  

  • 17. [Cycloserine and terizidone in the treatment of pulmonary tuberculosis: clinical study of tolerance].
    Rizzo A; Gomes A; Antunes G
    Rev Bras Med; 1969 Feb; 26(2):119-22. PubMed ID: 5797682
    [No Abstract]   [Full Text] [Related]  

  • 18. [Drug resistance of Mycobacterium tuberculosis during the cycloserine treatment of pulmonary tuberculosis patients].
    STEPANIAN ES; SERGEEV VV
    Probl Tuberk; 1962; 40(8)():84-7. PubMed ID: 13983851
    [No Abstract]   [Full Text] [Related]  

  • 19. Limitations of the clinical activity of cycloserine therapy. Appearance of resistance to cycloserine when used alone and in combination with other drugs.
    Molina C
    Scand J Respir Dis Suppl; 1970; 71():296-305. PubMed ID: 5272000
    [No Abstract]   [Full Text] [Related]  

  • 20. Serum levels, urinary excretion, and side-effects of cycloserine in the presence of isoniazid and p-aminosalicylic acid.
    Mattila MJ; Nieminen E; Tiitinen H
    Scand J Respir Dis; 1969; 50(4):291-300. PubMed ID: 5380786
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.